4
Changes in Ownership
Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-071472
Options or other derivatives
- Chief Executive Officer acquired 936,444 shares (grant or award)
- Chief Executive Officer returned 936,444 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Imran Talat · Chief Executive Officer
Table II: Derivative
8 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-16 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −479,667 | 95,933 | D |
| 2023-12-16 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +479,667 | 479,667 | D |
| 2023-12-16 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −153,650 | 109,750 | D |
| 2023-12-16 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +153,650 | 153,650 | D |
| 2023-12-16 | Returned to the company : show line 5 in the form Stock Option (Right to Buy) | −271,875 | 453,125 | D |
| 2023-12-16 | Grant or award : show line 6 in the form 271875 | +271,875 | 271,875 | D |
| 2023-12-16 | Returned to the company : show line 7 in the form Stock Option (Right to Buy) | −31,252 | 47,699 | D |
| 2023-12-16 | Grant or award : show line 8 in the form Stock Option (Right to Buy) | +31,252 | 31,252 | D |
Loading xslF345X05/ownership.xml…